Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-amlodipine + Chlorthalidone vs S-amlodipine + Telmisartan in Hypertension
NCT03226340Phase 4Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Dec 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of chlorthalidone in essential hypertension, sponsored by Seoul National University Bundang Hospital. Status: unknown.
02
Drugs
chlorthalidone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT03226340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03226340.